Nov 10, 2022 8:05 am EST MindMed Reports Third Quarter 2022 Financial Results and Business Highlights
Nov 03, 2022 7:30 am EDT MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update
Oct 05, 2022 8:35 am EDT MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference
Oct 04, 2022 7:30 am EDT MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA
Sep 20, 2022 7:30 am EDT MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances
Sep 08, 2022 7:30 am EDT MindMed Announces Positive Results from Collaborators' Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal